NPI registry status
Active
2026 NPPES data Oncology Pharmacist NPI 1740054204 PHARMD
Verify on CMS → Katie Bialick, PHARMD
Oncology Pharmacist in Seattle, Washington.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,916 in Oncology Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
56
Medicare Part D claims · 44 beneficiaries · Oncology Pharmacist avg: 157
Generic prescribing
34%
generic claims · 66% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Katie Bialick, PHARMD filed 56 Medicare Part D claims in 2024 as an Oncology Pharmacist in Seattle, Washington, prescribing 34% generic.
- 56
- Part D claims, 2024
- 34%
- generic prescribing
- ≥0th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Katie Bialick, PHARMD
Bare NPI registry listing — limited federal enrichment beyond basic enumeration. Verify all credentials with official sources.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1740054204), first enumerated 11/14/2023.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 56 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- State context
State board disciplinary context
Washington statewide board action statistics are published annually — these figures describe aggregate state activity, not Katie Bialick, PHARMD's individual license status. Verify directly with the state medical board.
Source: WMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1740054204 · Oncology Pharmacist
NPI-10 · ENUM-RECENT · TAX-NARROW · RX-TRACE · BOOK-THIN · PHOTO-ENUM
- NPI-10 1740054204
- ENUM-RECENT 2023
- TAX-NARROW 1,916
- RX-TRACE 56
- BOOK-THIN 86 in Washington
- PHOTO-ENUM Samuel Porter, PHARM… · 2023
Katie Bialick, PHARMD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
56 ≥ 0th percentile 0% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
What does the federal data show about Katie Bialick, PHARMD?
Quality data not reportedPrimary specialty
Oncology Pharmacist
Medicare Part D claims
56 64% vs specialty avg
Specialty distribution in Washington
How Oncology Pharmacist compares to other specialties among Washington providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Oncology Pharmacist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1740054204 |
|---|---|
| Specialty | Oncology Pharmacist |
| Credentials | PHARMD |
| Gender | Female |
| NPI Issued | 11/14/2023 |
License & disciplinary context - Washington WMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 - they are NOT specific to Katie Bialick, PHARMD. To verify Katie Bialick, PHARMD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Katie Bialick, PHARMD - brand share 66.0%
Oncology Pharmacist average
66% brand-name claims vs 34% generic, on 56 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
56
Total Claims
$967K
Total Drug Cost
44
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 56
- Total Day Supply
- 1,537
- Brand vs Generic
- 66% brand / 34% generic
- Brand Drug Cost
- $682K
- Generic Drug Cost
- $286K
Patient Demographics
- Average Patient Age
- 73.4 years
- Avg HCC Risk Score
- 3.05
- Gender Split
- 48% female / 52% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Katie Bialick, PHARMD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Revlimid
Revlimid
20 claims
- Lenalidomide
Lenalidomide
19 claims
- Pomalyst
Pomalyst
14 claims
| Drug | Claims |
|---|---|
| Revlimid Lenalidomide | 20 |
| Lenalidomide | 19 |
| Pomalyst Pomalidomide | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Oncology Pharmacist Overview
How Katie Bialick, PHARMD fits within the Oncology Pharmacist landscape nationally.
1,916
Oncology Pharmacist Providers in US
51
States with Oncology Pharmacist
157
Avg Claims per Provider
Katie Bialick, PHARMD's 56 claims are below the specialty average of 157.
Nationwide Oncology Pharmacist peers with similar MIPS or enrollment year
Two federal-record peer sets for Bialick, both outside Washington so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2023)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Oncology Pharmacist Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as Bialick.
One of 86 Oncology Pharmacist providers enrolled in Washington, 5 are shown here.
Dr. Laura Alwan
PHARMD
Seattle, WA
Grace Baek
Seattle, WA
Dr. Gordon Baldwin
PHARMD
Puyallup, WA
Dr. Sarah Balzar
PHARMD
Seattle, WA
Sonya Barich
Seattle, WA
Compare Oncology Pharmacist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Katie Bialick, PHARMD's specialty? ▼
Katie Bialick, PHARMD specializes in Oncology Pharmacist and practices in Seattle, Washington. Credentials: PHARMD.
How much does Katie Bialick, PHARMD prescribe under Medicare Part D? ▼
In 2024, Katie Bialick, PHARMD wrote 56 Medicare Part D claims totaling $967K in drug costs for 44 beneficiaries.
Where is Katie Bialick, PHARMD located? ▼
Katie Bialick, PHARMD is located at 825 EASTLAKE AVE E, Seattle, WA, 98109. Phone: (206) 606-7455.
What is Katie Bialick, PHARMD's NPI number? ▼
Katie Bialick, PHARMD's National Provider Identifier (NPI) is 1740054204, issued on 11/14/2023.
Does Katie Bialick, PHARMD prescribe more brand-name or generic drugs? ▼
Katie Bialick, PHARMD's prescribing is 66% brand-name and 34% generic drugs by claim count, with $682K in brand drug costs.
How many Oncology Pharmacist providers are there in the US? ▼
There are 1,916 Oncology Pharmacist providers across 51 states in the US. The average Oncology Pharmacist provider writes 157 Medicare Part D claims per year.
What drugs does Katie Bialick, PHARMD prescribe most often? ▼
Based on 2024 Medicare Part D data, Katie Bialick, PHARMD's most frequently prescribed drugs include Revlimid, Lenalidomide, Pomalyst. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Katie Bialick, PHARMD accept Medicare? ▼
Katie Bialick, PHARMD appears in CMS Medicare data with 56 Part D claims and 44 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Katie Bialick, PHARMD's credentials? ▼
Katie Bialick, PHARMD's NPI is 1740054204 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.